Best Medical Stocks To Follow Today - November 3rd

Key Points

• Seven medical stocks are highlighted for investors: Gilead Sciences, Stryker, Boston Scientific, Medtronic, McKesson, Medline, and ResMed ranked among the sector’s highest-dollar trading-volume stocks in recent days.
• Performance was mixed in Tuesday trading: Stryker, McKesson, and Medline gained, while Gilead Sciences, Boston Scientific, Medtronic, and ResMed declined. ResMed fell $8.91 to $224.03, while McKesson rose $2.79 to $1,001.17.
• The companies span pharmaceuticals, medical devices, healthcare distribution, supply-chain services, and respiratory care, offering exposure to several areas of the broader healthcare industry.

Gilead Sciences, Stryker, Boston Scientific, Medtronic, McKesson, Medline, and ResMed are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies involved in healthcare, including pharmaceutical and biotechnology firms, medical-device manufacturers, healthcare providers, and health insurers. Investors often evaluate these stocks based on factors such as drug approvals, clinical-trial results, regulatory changes, demand for healthcare services, and reimbursement conditions. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

NASDAQ:GILD traded down $1.13 during mid-day trading on Tuesday, reaching $169.20. The stock had a trading volume of 2,025,064 shares, compared to its average volume of 6,803,930. The company has a debt-to-equity ratio of 2.03, a current ratio of 1.27 and a quick ratio of 1.09. The company has a market capitalization of $209.80 billion, a price-to-earnings ratio of -53.54 and a beta of 0.31. Gilead Sciences has a 1-year low of $116.88 and a 1-year high of $175.65. The stock's 50 day simple moving average is $151.36 and its two-hundred day simple moving average is $140.03.

Read Our Latest Research Report on GILD

Stryker (SYK)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Shares of NYSE SYK traded up $2.07 during trading on Tuesday, reaching $308.88. The stock had a trading volume of 1,082,231 shares, compared to its average volume of 2,472,738. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. The stock has a market cap of $118.48 billion, a PE ratio of 32.88, a P/E/G ratio of 1.96 and a beta of 0.78. Stryker has a one year low of $267.00 and a one year high of $389.33. The firm's 50 day moving average price is $292.37 and its two-hundred day moving average price is $324.26.

Read Our Latest Research Report on SYK

Boston Scientific (BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system.

Boston Scientific stock traded down $0.61 during mid-day trading on Tuesday, reaching $43.71. The company's stock had a trading volume of 7,563,992 shares, compared to its average volume of 18,720,777. The firm has a market cap of $63.35 billion, a price-to-earnings ratio of 18.55, a PEG ratio of 1.04 and a beta of 0.58. The business has a 50 day moving average price of $44.66 and a 200-day moving average price of $56.63. The company has a current ratio of 1.24, a quick ratio of 0.74 and a debt-to-equity ratio of 0.43. Boston Scientific has a twelve month low of $39.57 and a twelve month high of $105.65.

Read Our Latest Research Report on BSX

Medtronic (MDT)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

Shares of NYSE:MDT traded down $0.24 on Tuesday, reaching $99.05. 2,751,079 shares of the company's stock were exchanged, compared to its average volume of 11,314,917. The firm has a market capitalization of $126.70 billion, a price-to-earnings ratio of 24.39, a PEG ratio of 2.22 and a beta of 0.56. Medtronic has a fifty-two week low of $73.31 and a fifty-two week high of $106.33. The business's 50-day moving average is $91.82 and its two-hundred day moving average is $88.36. The company has a quick ratio of 1.54, a current ratio of 2.07 and a debt-to-equity ratio of 0.50.

Read Our Latest Research Report on MDT

McKesson (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Shares of NYSE MCK traded up $2.79 during midday trading on Tuesday, hitting $1,001.17. The company's stock had a trading volume of 271,023 shares, compared to its average volume of 915,142. McKesson has a 1-year low of $723.68 and a 1-year high of $1,030.27. The firm's fifty day moving average price is $925.32 and its 200-day moving average price is $863.78. The firm has a market cap of $116.73 billion, a P/E ratio of 26.83, a P/E/G ratio of 1.91 and a beta of 0.30.

Read Our Latest Research Report on MCK

Medline (MDLN)

Our mission is to make healthcare run better by delivering improved clinical, financial, and operational outcomes. We are the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. We deliver mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities.

MDLN traded up $0.19 on Tuesday, hitting $33.82. 6,296,316 shares of the company's stock were exchanged, compared to its average volume of 7,620,895. The company has a current ratio of 4.33, a quick ratio of 2.61 and a debt-to-equity ratio of 0.66. The stock has a fifty day moving average of $34.50 and a two-hundred day moving average of $39.59. Medline has a twelve month low of $31.37 and a twelve month high of $50.88. The firm has a market cap of $44.46 billion and a PE ratio of 42.81.

Read Our Latest Research Report on MDLN

ResMed (RMD)

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.

Shares of NYSE RMD traded down $8.91 during mid-day trading on Tuesday, hitting $224.03. The company had a trading volume of 916,943 shares, compared to its average volume of 1,302,255. ResMed has a 12 month low of $180.26 and a 12 month high of $277.67. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.10 and a quick ratio of 2.42. The firm's 50 day simple moving average is $231.89 and its two-hundred day simple moving average is $225.33. The stock has a market cap of $31.51 billion, a price-to-earnings ratio of 20.40, a PEG ratio of 1.53 and a beta of 0.77.

Read Our Latest Research Report on RMD

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.